Amfetamine sulfate/Dexamfetamine sulfate/Amfetamine aspartate/Dexamfetamine saccharate

N/A

Report date: 2025/12/26 17:53:58

Base Information

Drug NameAmfetamine sulfate/Dexamfetamine sulfate/Amfetamine aspartate/Dexamfetamine saccharate
Drug Alias NameAmphetamine salts (mixed, extended release) - Takedad,l-Amphetamine and dextroamphetamine salts (extended release) - TakedaDextroamphetamine and d,l-amphetamine salts (extended release) - Takedad-Amphetamine and d,l-amphetamine salts (extended release) - Takedad,l-Amphetamine and d-amphetamine salts (extended release) - Takeda +[12] 
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonistsCentral nervous system stimulants
TargetsAdrenergic receptors
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorCocaine-Related Disorders
Global Approved IndicationsAttention Deficit Disorder with Hyperactivity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1960/01/19
Country/TerritoryUnited States
CombinationsYes Amfetamine SulfateDexamfetamine Sulfate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Los Angeles
Inactive CompaniesShireNew York State Psychiatric InstituteTeva Women'S Health Llc
Active IndicationsDepressive Disorder, Major
Inactive IndicationsAttention Deficit Disorder with HyperactivityCocaine-Related Disorders

Other Information

ATC CodeN/A
Related LinksWikipedia